自閉症スペクトラム障害（ASD）治療の世界市場（～2026年）

• 英文タイトル：Global Autism Spectrum Disorder (ASD) Treatment Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY10928
• 出版社/出版日：QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、94ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は自閉症スペクトラム障害（ASD）治療のグローバル市場について調査・分析したレポートです。種類別（自閉症、アスペルガー症候群、広汎性発達障害、小児期崩壊性障害）市場規模、用途別（病院・クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別自閉症スペクトラム障害（ASD）治療の競争状況、市場シェア
・世界の自閉症スペクトラム障害（ASD）治療市場：種類別市場規模 2015年-2020年（自閉症、アスペルガー症候群、広汎性発達障害、小児期崩壊性障害）
・世界の自閉症スペクトラム障害（ASD）治療市場：種類別市場規模予測 2021年-2026年（自閉症、アスペルガー症候群、広汎性発達障害、小児期崩壊性障害）
・世界の自閉症スペクトラム障害（ASD）治療市場：用途別市場規模 2015年-2020年（病院・クリニック、その他）
・世界の自閉症スペクトラム障害（ASD）治療市場：用途別市場規模予測 2021年-2026年（病院・クリニック、その他）
・北米の自閉症スペクトラム障害（ASD）治療市場分析：米国、カナダ
・ヨーロッパの自閉症スペクトラム障害（ASD）治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの自閉症スペクトラム障害（ASD）治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の自閉症スペクトラム障害（ASD）治療市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの自閉症スペクトラム障害（ASD）治療市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Pfizer、SynapDx、Behavior Analysis、Autism Therapeutics、Curemark、Roche Pharmaceuticals、Fraser、Retrophin、AutismSTEP
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Autism spectrum disorder (ASD) refers to a group of complex neurodevelopment disorders characterized by repetitive and characteristic patterns of behavior and difficulties with social communication and interaction.
According to CDC statistics, 1 in every 68 children suffers with autism. Innovative drugs and better treatment approaches are expected to drive the growth of market in the coming years.

Market Analysis and Insights: Global Autism Spectrum Disorder (ASD) Treatment Market
The global Autism Spectrum Disorder (ASD) Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Autism Spectrum Disorder (ASD) Treatment Scope and Market Size
Autism Spectrum Disorder (ASD) Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Autism Spectrum Disorder (ASD) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Pfizer
SynapDx
Behavior Analysis
Autism Therapeutics
Curemark
Roche Pharmaceuticals
Fraser
Retrophin
AutismSTEP

Market segment by Type, the product can be split into
Autistic Disorder
Asperger Syndrome
Pervasive Developmental Disorder
Childhood Disintegrative Disorder
Market segment by Application, split into
Hospitals and Clinics
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Autism Spectrum Disorder (ASD) Treatment Revenue
1.4 Market by Type
1.4.1 Global Autism Spectrum Disorder (ASD) Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Autistic Disorder
1.4.3 Asperger Syndrome
1.4.4 Pervasive Developmental Disorder
1.4.5 Childhood Disintegrative Disorder
1.5 Market by Application
1.5.1 Global Autism Spectrum Disorder (ASD) Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals and Clinics
1.5.3 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Autism Spectrum Disorder (ASD) Treatment Market Perspective (2015-2026)
2.2 Global Autism Spectrum Disorder (ASD) Treatment Growth Trends by Regions
2.2.1 Autism Spectrum Disorder (ASD) Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Autism Spectrum Disorder (ASD) Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Autism Spectrum Disorder (ASD) Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Autism Spectrum Disorder (ASD) Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Autism Spectrum Disorder (ASD) Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Autism Spectrum Disorder (ASD) Treatment Players by Market Size
3.1.1 Global Top Autism Spectrum Disorder (ASD) Treatment Players by Revenue (2015-2020)
3.1.2 Global Autism Spectrum Disorder (ASD) Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Autism Spectrum Disorder (ASD) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Autism Spectrum Disorder (ASD) Treatment Market Concentration Ratio
3.2.1 Global Autism Spectrum Disorder (ASD) Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Autism Spectrum Disorder (ASD) Treatment Revenue in 2019
3.3 Autism Spectrum Disorder (ASD) Treatment Key Players Head office and Area Served
3.4 Key Players Autism Spectrum Disorder (ASD) Treatment Product Solution and Service
3.5 Date of Enter into Autism Spectrum Disorder (ASD) Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Autism Spectrum Disorder (ASD) Treatment Historic Market Size by Type (2015-2020)
4.2 Global Autism Spectrum Disorder (ASD) Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Autism Spectrum Disorder (ASD) Treatment Market Size by Application (2015-2020)
5.2 Global Autism Spectrum Disorder (ASD) Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Autism Spectrum Disorder (ASD) Treatment Market Size (2015-2020)
6.2 Autism Spectrum Disorder (ASD) Treatment Key Players in North America (2019-2020)
6.3 North America Autism Spectrum Disorder (ASD) Treatment Market Size by Type (2015-2020)
6.4 North America Autism Spectrum Disorder (ASD) Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Autism Spectrum Disorder (ASD) Treatment Market Size (2015-2020)
7.2 Autism Spectrum Disorder (ASD) Treatment Key Players in Europe (2019-2020)
7.3 Europe Autism Spectrum Disorder (ASD) Treatment Market Size by Type (2015-2020)
7.4 Europe Autism Spectrum Disorder (ASD) Treatment Market Size by Application (2015-2020)

8 China
8.1 China Autism Spectrum Disorder (ASD) Treatment Market Size (2015-2020)
8.2 Autism Spectrum Disorder (ASD) Treatment Key Players in China (2019-2020)
8.3 China Autism Spectrum Disorder (ASD) Treatment Market Size by Type (2015-2020)
8.4 China Autism Spectrum Disorder (ASD) Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Autism Spectrum Disorder (ASD) Treatment Market Size (2015-2020)
9.2 Autism Spectrum Disorder (ASD) Treatment Key Players in Japan (2019-2020)
9.3 Japan Autism Spectrum Disorder (ASD) Treatment Market Size by Type (2015-2020)
9.4 Japan Autism Spectrum Disorder (ASD) Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Autism Spectrum Disorder (ASD) Treatment Market Size (2015-2020)
10.2 Autism Spectrum Disorder (ASD) Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Autism Spectrum Disorder (ASD) Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Autism Spectrum Disorder (ASD) Treatment Market Size by Application (2015-2020)

11 India
11.1 India Autism Spectrum Disorder (ASD) Treatment Market Size (2015-2020)
11.2 Autism Spectrum Disorder (ASD) Treatment Key Players in India (2019-2020)
11.3 India Autism Spectrum Disorder (ASD) Treatment Market Size by Type (2015-2020)
11.4 India Autism Spectrum Disorder (ASD) Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Autism Spectrum Disorder (ASD) Treatment Market Size (2015-2020)
12.2 Autism Spectrum Disorder (ASD) Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Autism Spectrum Disorder (ASD) Treatment Market Size by Type (2015-2020)
12.4 Central & South America Autism Spectrum Disorder (ASD) Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Autism Spectrum Disorder (ASD) Treatment Introduction
13.1.4 Pfizer Revenue in Autism Spectrum Disorder (ASD) Treatment Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 SynapDx
13.2.1 SynapDx Company Details
13.2.2 SynapDx Business Overview
13.2.3 SynapDx Autism Spectrum Disorder (ASD) Treatment Introduction
13.2.4 SynapDx Revenue in Autism Spectrum Disorder (ASD) Treatment Business (2015-2020)
13.2.5 SynapDx Recent Development
13.3 Behavior Analysis
13.3.1 Behavior Analysis Company Details
13.3.2 Behavior Analysis Business Overview
13.3.3 Behavior Analysis Autism Spectrum Disorder (ASD) Treatment Introduction
13.3.4 Behavior Analysis Revenue in Autism Spectrum Disorder (ASD) Treatment Business (2015-2020)
13.3.5 Behavior Analysis Recent Development
13.4 Autism Therapeutics
13.4.1 Autism Therapeutics Company Details
13.4.2 Autism Therapeutics Business Overview
13.4.3 Autism Therapeutics Autism Spectrum Disorder (ASD) Treatment Introduction
13.4.4 Autism Therapeutics Revenue in Autism Spectrum Disorder (ASD) Treatment Business (2015-2020)
13.4.5 Autism Therapeutics Recent Development
13.5 Curemark
13.5.1 Curemark Company Details
13.5.2 Curemark Business Overview
13.5.3 Curemark Autism Spectrum Disorder (ASD) Treatment Introduction
13.5.4 Curemark Revenue in Autism Spectrum Disorder (ASD) Treatment Business (2015-2020)
13.5.5 Curemark Recent Development
13.6 Roche Pharmaceuticals
13.6.1 Roche Pharmaceuticals Company Details
13.6.2 Roche Pharmaceuticals Business Overview
13.6.3 Roche Pharmaceuticals Autism Spectrum Disorder (ASD) Treatment Introduction
13.6.4 Roche Pharmaceuticals Revenue in Autism Spectrum Disorder (ASD) Treatment Business (2015-2020)
13.6.5 Roche Pharmaceuticals Recent Development
13.7 Fraser
13.7.1 Fraser Company Details
13.7.2 Fraser Business Overview
13.7.3 Fraser Autism Spectrum Disorder (ASD) Treatment Introduction
13.7.4 Fraser Revenue in Autism Spectrum Disorder (ASD) Treatment Business (2015-2020)
13.7.5 Fraser Recent Development
13.8 Retrophin
13.8.1 Retrophin Company Details
13.8.2 Retrophin Business Overview
13.8.3 Retrophin Autism Spectrum Disorder (ASD) Treatment Introduction
13.8.4 Retrophin Revenue in Autism Spectrum Disorder (ASD) Treatment Business (2015-2020)
13.8.5 Retrophin Recent Development
13.9 AutismSTEP
13.9.1 AutismSTEP Company Details
13.9.2 AutismSTEP Business Overview
13.9.3 AutismSTEP Autism Spectrum Disorder (ASD) Treatment Introduction
13.9.4 AutismSTEP Revenue in Autism Spectrum Disorder (ASD) Treatment Business (2015-2020)
13.9.5 AutismSTEP Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Autism Spectrum Disorder (ASD) Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Autism Spectrum Disorder (ASD) Treatment Revenue
Table 3. Ranking of Global Top Autism Spectrum Disorder (ASD) Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Autism Spectrum Disorder (ASD) Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Autistic Disorder
Table 6. Key Players of Asperger Syndrome
Table 7. Key Players of Pervasive Developmental Disorder
Table 8. Key Players of Childhood Disintegrative Disorder
Table 9. Global Autism Spectrum Disorder (ASD) Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Autism Spectrum Disorder (ASD) Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Autism Spectrum Disorder (ASD) Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Autism Spectrum Disorder (ASD) Treatment Market Share by Regions (2015-2020)
Table 13. Global Autism Spectrum Disorder (ASD) Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Autism Spectrum Disorder (ASD) Treatment Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Autism Spectrum Disorder (ASD) Treatment Market Growth Strategy
Table 19. Main Points Interviewed from Key Autism Spectrum Disorder (ASD) Treatment Players
Table 20. Global Autism Spectrum Disorder (ASD) Treatment Revenue by Players (2015-2020) (Million US$)
Table 21. Global Autism Spectrum Disorder (ASD) Treatment Market Share by Players (2015-2020)
Table 22. Global Top Autism Spectrum Disorder (ASD) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autism Spectrum Disorder (ASD) Treatment as of 2019)
Table 23. Global Autism Spectrum Disorder (ASD) Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Autism Spectrum Disorder (ASD) Treatment Product Solution and Service
Table 26. Date of Enter into Autism Spectrum Disorder (ASD) Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Autism Spectrum Disorder (ASD) Treatment Market Size by Type (2015-2020) (Million US$)
Table 29. Global Autism Spectrum Disorder (ASD) Treatment Market Size Share by Type (2015-2020)
Table 30. Global Autism Spectrum Disorder (ASD) Treatment Revenue Market Share by Type (2021-2026)
Table 31. Global Autism Spectrum Disorder (ASD) Treatment Market Size Share by Application (2015-2020)
Table 32. Global Autism Spectrum Disorder (ASD) Treatment Market Size by Application (2015-2020) (Million US$)
Table 33. Global Autism Spectrum Disorder (ASD) Treatment Market Size Share by Application (2021-2026)
Table 34. North America Key Players Autism Spectrum Disorder (ASD) Treatment Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Autism Spectrum Disorder (ASD) Treatment Market Share (2019-2020)
Table 36. North America Autism Spectrum Disorder (ASD) Treatment Market Size by Type (2015-2020) (Million US$)
Table 37. North America Autism Spectrum Disorder (ASD) Treatment Market Share by Type (2015-2020)
Table 38. North America Autism Spectrum Disorder (ASD) Treatment Market Size by Application (2015-2020) (Million US$)
Table 39. North America Autism Spectrum Disorder (ASD) Treatment Market Share by Application (2015-2020)
Table 40. Europe Key Players Autism Spectrum Disorder (ASD) Treatment Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Autism Spectrum Disorder (ASD) Treatment Market Share (2019-2020)
Table 42. Europe Autism Spectrum Disorder (ASD) Treatment Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Autism Spectrum Disorder (ASD) Treatment Market Share by Type (2015-2020)
Table 44. Europe Autism Spectrum Disorder (ASD) Treatment Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Autism Spectrum Disorder (ASD) Treatment Market Share by Application (2015-2020)
Table 46. China Key Players Autism Spectrum Disorder (ASD) Treatment Revenue (2019-2020) (Million US$)
Table 47. China Key Players Autism Spectrum Disorder (ASD) Treatment Market Share (2019-2020)
Table 48. China Autism Spectrum Disorder (ASD) Treatment Market Size by Type (2015-2020) (Million US$)
Table 49. China Autism Spectrum Disorder (ASD) Treatment Market Share by Type (2015-2020)
Table 50. China Autism Spectrum Disorder (ASD) Treatment Market Size by Application (2015-2020) (Million US$)
Table 51. China Autism Spectrum Disorder (ASD) Treatment Market Share by Application (2015-2020)
Table 52. Japan Key Players Autism Spectrum Disorder (ASD) Treatment Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Autism Spectrum Disorder (ASD) Treatment Market Share (2019-2020)
Table 54. Japan Autism Spectrum Disorder (ASD) Treatment Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Autism Spectrum Disorder (ASD) Treatment Market Share by Type (2015-2020)
Table 56. Japan Autism Spectrum Disorder (ASD) Treatment Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Autism Spectrum Disorder (ASD) Treatment Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Autism Spectrum Disorder (ASD) Treatment Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Autism Spectrum Disorder (ASD) Treatment Market Share (2019-2020)
Table 60. Southeast Asia Autism Spectrum Disorder (ASD) Treatment Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Autism Spectrum Disorder (ASD) Treatment Market Share by Type (2015-2020)
Table 62. Southeast Asia Autism Spectrum Disorder (ASD) Treatment Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Autism Spectrum Disorder (ASD) Treatment Market Share by Application (2015-2020)
Table 64. India Key Players Autism Spectrum Disorder (ASD) Treatment Revenue (2019-2020) (Million US$)
Table 65. India Key Players Autism Spectrum Disorder (ASD) Treatment Market Share (2019-2020)
Table 66. India Autism Spectrum Disorder (ASD) Treatment Market Size by Type (2015-2020) (Million US$)
Table 67. India Autism Spectrum Disorder (ASD) Treatment Market Share by Type (2015-2020)
Table 68. India Autism Spectrum Disorder (ASD) Treatment Market Size by Application (2015-2020) (Million US$)
Table 69. India Autism Spectrum Disorder (ASD) Treatment Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Autism Spectrum Disorder (ASD) Treatment Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Autism Spectrum Disorder (ASD) Treatment Market Share (2019-2020)
Table 72. Central & South America Autism Spectrum Disorder (ASD) Treatment Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Autism Spectrum Disorder (ASD) Treatment Market Share by Type (2015-2020)
Table 74. Central & South America Autism Spectrum Disorder (ASD) Treatment Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Autism Spectrum Disorder (ASD) Treatment Market Share by Application (2015-2020)
Table 76. Pfizer Company Details
Table 77. Pfizer Business Overview
Table 78. Pfizer Product
Table 79. Pfizer Revenue in Autism Spectrum Disorder (ASD) Treatment Business (2015-2020) (Million US$)
Table 80. Pfizer Recent Development
Table 81. SynapDx Company Details
Table 82. SynapDx Business Overview
Table 83. SynapDx Product
Table 84. SynapDx Revenue in Autism Spectrum Disorder (ASD) Treatment Business (2015-2020) (Million US$)
Table 85. SynapDx Recent Development
Table 86. Behavior Analysis Company Details
Table 87. Behavior Analysis Business Overview
Table 88. Behavior Analysis Product
Table 89. Behavior Analysis Revenue in Autism Spectrum Disorder (ASD) Treatment Business (2015-2020) (Million US$)
Table 90. Behavior Analysis Recent Development
Table 91. Autism Therapeutics Company Details
Table 92. Autism Therapeutics Business Overview
Table 93. Autism Therapeutics Product
Table 94. Autism Therapeutics Revenue in Autism Spectrum Disorder (ASD) Treatment Business (2015-2020) (Million US$)
Table 95. Autism Therapeutics Recent Development
Table 96. Curemark Company Details
Table 97. Curemark Business Overview
Table 98. Curemark Product
Table 99. Curemark Revenue in Autism Spectrum Disorder (ASD) Treatment Business (2015-2020) (Million US$)
Table 100. Curemark Recent Development
Table 101. Roche Pharmaceuticals Company Details
Table 102. Roche Pharmaceuticals Business Overview
Table 103. Roche Pharmaceuticals Product
Table 104. Roche Pharmaceuticals Revenue in Autism Spectrum Disorder (ASD) Treatment Business (2015-2020) (Million US$)
Table 105. Roche Pharmaceuticals Recent Development
Table 106. Fraser Company Details
Table 107. Fraser Business Overview
Table 108. Fraser Product
Table 109. Fraser Revenue in Autism Spectrum Disorder (ASD) Treatment Business (2015-2020) (Million US$)
Table 110. Fraser Recent Development
Table 111. Retrophin Business Overview
Table 112. Retrophin Product
Table 113. Retrophin Company Details
Table 114. Retrophin Revenue in Autism Spectrum Disorder (ASD) Treatment Business (2015-2020) (Million US$)
Table 115. Retrophin Recent Development
Table 116. AutismSTEP Company Details
Table 117. AutismSTEP Business Overview
Table 118. AutismSTEP Product
Table 119. AutismSTEP Revenue in Autism Spectrum Disorder (ASD) Treatment Business (2015-2020) (Million US$)
Table 120. AutismSTEP Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Autism Spectrum Disorder (ASD) Treatment Market Share by Type: 2020 VS 2026
Figure 2. Autistic Disorder Features
Figure 3. Asperger Syndrome Features
Figure 4. Pervasive Developmental Disorder Features
Figure 5. Childhood Disintegrative Disorder Features
Figure 6. Global Autism Spectrum Disorder (ASD) Treatment Market Share by Application: 2020 VS 2026
Figure 7. Hospitals and Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Autism Spectrum Disorder (ASD) Treatment Report Years Considered
Figure 10. Global Autism Spectrum Disorder (ASD) Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Autism Spectrum Disorder (ASD) Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Autism Spectrum Disorder (ASD) Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Autism Spectrum Disorder (ASD) Treatment Market Share by Players in 2019
Figure 15. Global Top Autism Spectrum Disorder (ASD) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autism Spectrum Disorder (ASD) Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Autism Spectrum Disorder (ASD) Treatment Revenue in 2019
Figure 17. North America Autism Spectrum Disorder (ASD) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Autism Spectrum Disorder (ASD) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Autism Spectrum Disorder (ASD) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Autism Spectrum Disorder (ASD) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Autism Spectrum Disorder (ASD) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Autism Spectrum Disorder (ASD) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Autism Spectrum Disorder (ASD) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed

以下、関連資料のご紹介

胎児性アルコールスペクトラム障害（FASD）治療の世界市場（～2026年）

Global Fetal Alcohol Spectrum Disorder Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11930 2020年11月25日 97Pages
当調査資料は胎児性アルコールスペクトラム障害（FASD）治療のグローバル市場について調査・分析したレポートです。種類別（抗うつ薬、覚醒剤、神経弛緩薬、抗不安薬）市場規模、用途別（病院薬局、小売薬局、ドラッグストア、Eコマース）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリ...

脂質異常症治療の世界市場（～2026年）

Global Lipid Disorder Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12520 2020年11月25日 92Pages
当調査資料は脂質異常症治療のグローバル市場について調査・分析したレポートです。種類別（アトルバスタチン、フルバスタチン、ロスバスタチン、シンバスタチン、プラバスタチン、その他薬剤）市場規模、用途別（病院、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス...

甲状腺障害治療の世界市場（～2026年）

Global Thyroid Gland Disorder Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04853 2020年11月20日 93Pages
当調査資料は甲状腺障害治療のグローバル市場について調査・分析したレポートです。種類別（甲状腺機能亢進症、甲状腺機能低下症、その他）市場規模、用途別（男性、女性）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラ...

ENT疾患治療の世界市場（～2026年）

Global ENT Disorder Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11841 2020年11月25日 92Pages
当調査資料はENT疾患治療のグローバル市場について調査・分析したレポートです。種類別（扁桃炎、耳感染症、副鼻腔感染症、睡眠時無呼吸）市場規模、用途別（病院、クリニック、外来手術センター、在宅介護施設、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシ...

季節性情動障害治療の世界市場（～2026年）

Global Seasonal Affective Disorder Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04565 2020年11月20日 90Pages
当調査資料は季節性情動障害治療のグローバル市場について調査・分析したレポートです。種類別（光線療法（光線療法）、薬物、心理療法、カウンセリング、その他）市場規模、用途別（病院、診療所、医学研究センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロ...

認知症・運動障害治療の世界市場（～2026年）

Global Dementia and Movement Disorder Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11592 2020年11月25日 94Pages
当調査資料は認知症・運動障害治療のグローバル市場について調査・分析したレポートです。種類別（MAO阻害剤（モノアミン酸化酵素）、AChE阻害剤（アセチルコリンエステラーゼ）、グルタミン酸阻害剤）市場規模、用途別（ブランド薬品、ジェネリック薬品）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ...

強迫性障害治療の世界市場（～2026年）

Global Obsessive-Compulsive Disorder Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04031 2020年11月20日 90Pages
当調査資料は強迫性障害治療のグローバル市場について調査・分析したレポートです。種類別（ADX-88178、ビトペルチン、CR-5542、ジプラグラントIR、マレイン酸フルボキサミン、マボグルラント、その他）市場規模、用途別（クリニック、病院、研究センター）市場規模、地域別（北米、米国、カナダ、ヨーロ...

慢性うつ病性人格障害治療の世界市場（～2026年）

Global Chronic Depressive Personality Disorder Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11360 2020年11月25日 96Pages
当調査資料は慢性うつ病性人格障害治療のグローバル市場について調査・分析したレポートです。種類別（選択的セロトニン再取り込み阻害薬、三環系抗うつ薬、ノルエピネフリン再取り込み阻害薬、その他）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、...

多形性膠芽腫（GBM）治療の世界市場（～2026年）

Global Glioblastoma Multiforme Treatment (GBM) Market Size, Status and Forecast 2020-2026
MRC2-11QY12056 2020年11月25日 92Pages
当調査資料は多形性膠芽腫（GBM）治療のグローバル市場について調査・分析したレポートです。種類別（化学療法、放射線療法、遺伝子治療、分子バイオテクノロジー）市場規模、用途別（ベバコズマブ、カルムスチン、テモゾロミド）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリ...

神経精神障害・治療の世界市場（～2026年）

Global Neuropsychiatric Disorders And Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY03957 2020年11月20日 97Pages
当調査資料は神経精神障害・治療のグローバル市場について調査・分析したレポートです。種類別（変性疾患、神経症、精神病）市場規模、用途別（病院、診療所、研究センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オースト...

胎児性アルコールスペクトラム障害（FASD）治療の世界市場（～2026年） Fetal alcohol spectrum disorder are the group of conditions occurring in new born with a wide range of disabilities. Fetal alcohol spectrum disorder treatment market is an evolving market owing to the gradual change in the lifestyle and increased alcohol consumption by pregnant women, eventually inc…
脂質異常症治療の世界市場（～2026年） Lipid disorder means the people high blood levels of low-density lipoprotein (LDL) cholesterol, fats called triglycerides,. Several biopharma companies are focusing on developing effective solutions for treating lipid disorders. Companies involved in lipid disorder treatment market include Teva Phar…
甲状腺障害治療の世界市場（～2026年） Hormones released by thyroid gland play a crucial role in stimulating metabolism, growth, and calories processing. Globally, thyroid gland disorders such as hypothyroidism, hyperthyroidism, and thyroid nodules affect around 5% to 10% of the population. Hyperthyroidism and hypothyroidism affect major…
ENT疾患治療の世界市場（～2026年） ENT is a medical abbreviation for ears, nose and throat. Major factor contributing to growth of the global ENT disorder treatment market includes increasing pollution. Market Analysis and Insights: Global ENT Disorder Treatment Market The global ENT Disorder Treatment market size is projected to rea…
季節性情動障害治療の世界市場（～2026年） Seasonal Affective Disorder is a type of depression that occurs during a certain time of the year. This disorder is related to changes in seasons, mostly occurs in winter but some people may have this disorder in summers as well. Seasonal affective disorder is most common in women, people between th…